tiprankstipranks
Eastwood Bio-Medical Canada Inc (TSE:EBM)
TSXV:EBM
Canadian Market
Holding TSE:EBM?
Track your performance easily

Eastwood Bio-Medical Canada (EBM) Stock Price & Analysis

5 Followers

EBM Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

0.01%99.99%
― Other Institutional Investors
99.99% Public Companies and
Individual Investors

EBM FAQ

What was Eastwood Bio-Medical Canada Inc’s price range in the past 12 months?
Eastwood Bio-Medical Canada Inc lowest stock price was C$0.25 and its highest was C$1.15 in the past 12 months.
    What is Eastwood Bio-Medical Canada Inc’s market cap?
    Currently, no data Available
    When is Eastwood Bio-Medical Canada Inc’s upcoming earnings report date?
    Eastwood Bio-Medical Canada Inc’s upcoming earnings report date is Mar 28, 2025 which is in 125 days.
      How were Eastwood Bio-Medical Canada Inc’s earnings last quarter?
      Eastwood Bio-Medical Canada Inc released its earnings results on Sep 26, 2024. The company reported -C$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.002.
        Is Eastwood Bio-Medical Canada Inc overvalued?
        According to Wall Street analysts Eastwood Bio-Medical Canada Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Eastwood Bio-Medical Canada Inc pay dividends?
          Eastwood Bio-Medical Canada Inc does not currently pay dividends.
          What is Eastwood Bio-Medical Canada Inc’s EPS estimate?
          Eastwood Bio-Medical Canada Inc’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Eastwood Bio-Medical Canada Inc have?
          Eastwood Bio-Medical Canada Inc has 68,885,970 shares outstanding.
            What happened to Eastwood Bio-Medical Canada Inc’s price movement after its last earnings report?
            Eastwood Bio-Medical Canada Inc reported an EPS of -C$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of Eastwood Bio-Medical Canada Inc?
              Currently, no hedge funds are holding shares in TSE:EBM
              ---

              Eastwood Bio-Medical Canada Stock Smart Score

              10
              Unlock Smart Score
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Company Description

              Eastwood Bio-Medical Canada Inc

              Eastwood Bio-Medical Canada Inc is engaged in the development and commercialization of safe and effective treatment for non-insulin dependent diabetes mellitus (NIDDM-Type II diabetes). The company's Eleotin brand of products provide natural sourced solutions for metabolic syndromes such as blood glucose control, obesity, and hypertension. Eleotin was initially developed by the scientists at the Julia McFarlane Diabetes Research Center (JMDRC) at the University of Calgary in Alberta, Canada. After the initial development by the JMDRC, research and development were continued by Eastwood Bio-Medical Research Inc., the Company, and other institutions around the world, including Tsinghua University of the People's Republic of China.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              BriaCell Therapeutics
              Reliq Health Technologies
              Revive Therapeutics
              Helix BioPharma
              Popular Stocks
              ---
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis